AltheaDx employs Wendy Benson as CEO
This article was originally published in Clinica
Molecular diagnostics firm AltheaDx has appointed Wendy Benson to the position of CEO and president. She will replace interim co-CEOs, Dr François Ferré and Dr Magda Marquet, who will remain at the firm as co-chairs on the company’s board. Ms Benson was recently president and CEO at infectious disease specialist HX Diagnostics and has previously worked at Roche Molecular Diagnostics, Ortho Clinical Diagnostics and Genetic Systems. Ms Benson will also join AltheaDx’s board of directors along with Ann Kessler, former director of international project management at Hoffman-La Roche. Dr Kessler joins the firm as an independent director.